New Poster: Immune responses to repeated application of the contact allergen diphenylcyclopropenone (DPC) in humans: evidence of down-regulatory mechanisms

Share

This research to understand the underpinning immune response in alopecia patients undergoing treatment with the experimental skin sensitiser diphenylcyclopropenone (DPC) is part of our T cell forum programme of research, which aims to improve skin allergy risk assessment through increased mechanistic and clinical understanding.

View the poster here.

Comments are closed.